ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1050
-0.0110 (-9.48%)
At close: Jul 30, 2026
ZyVersa Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Selling, General & Admin | 1.25 | 0.47 | 1.74 | 1.63 | 1.89 | 1.17 | 1.83 | 2.04 | 2.31 | 1.52 | 2.23 | 3.93 | 3.54 | 3.5 | 1.06 | 1.16 | 2.3 | 1.14 | 1.71 | 1.35 |
Research & Development | 0.06 | 0.08 | 0.37 | 0.41 | 0.26 | 0.12 | 0.44 | 0.71 | 0.51 | 0.26 | 0.67 | 1.22 | 1.06 | 1.69 | 2.33 | 0.72 | 1.07 | 0.63 | 0.41 | 0.5 |
Operating Expenses | 1.3 | 0.55 | 2.1 | 2.04 | 2.14 | 1.29 | 2.27 | 2.75 | 2.83 | 1.78 | 2.9 | 5.15 | 4.59 | 5.19 | 3.4 | 1.88 | 3.37 | 1.78 | 2.11 | 1.85 |
Operating Income | -1.3 | -0.55 | -2.1 | -2.04 | -2.14 | -1.29 | -2.27 | -2.75 | -2.83 | -1.78 | -2.9 | -5.15 | -4.59 | -5.19 | -3.4 | -1.88 | -3.37 | -1.78 | -2.11 | -1.85 |
Interest Expense | -0.13 | -0.13 | -0.13 | -0.13 | -0.12 | -0.14 | -0.13 | -0 | -0 | -0 | -0 | -0 | - | -0.05 | -0.07 | -0.14 | -0.17 | -0.2 | -0.23 | -0.22 |
Interest & Investment Income | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - | - | - | - |
Other Non Operating Income (Expenses) | -0.01 | -0.2 | 0.23 | -0.04 | 0.01 | - | - | - | - | - | - | - | - | -0.19 | -0.23 | 0.02 | -0.21 | 0.01 | 0.25 | -0.02 |
EBT Excluding Unusual Items | -1.45 | -0.88 | -2.01 | -2.21 | -2.26 | -1.42 | -2.4 | -2.75 | -2.83 | -1.78 | -2.9 | -5.15 | -4.59 | -5.42 | -3.69 | -2 | -3.75 | -1.97 | -2.09 | -2.1 |
Impairment of Goodwill | - | - | - | - | - | - | - | - | - | - | - | -11.9 | - | - | - | - | - | - | - | - |
Other Unusual Items | -0.34 | 0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.21 | - |
Pretax Income | -1.79 | -0.68 | -20.66 | -2.21 | -2.26 | -1.42 | -2.4 | -2.75 | -2.83 | -13.93 | -2.9 | -86.33 | -4.59 | -5.42 | -3.69 | -2 | -3.75 | -1.97 | -1.88 | -2.1 |
Income Tax Expense | - | - | -0.85 | - | - | -0 | - | 0.01 | - | -0.6 | -0 | -7.81 | -1.05 | -0.75 | - | - | - | - | - | - |
Net Income | -1.79 | -0.68 | -19.81 | -2.21 | -2.26 | -1.42 | -2.4 | -2.76 | -2.83 | -13.34 | -2.9 | -78.51 | -3.54 | -4.68 | -3.69 | -2 | -3.75 | -1.97 | -1.88 | -2.1 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | - | - | - | - | - | 0.03 | 7.92 | - | -10.02 | 9.68 | 0.33 | - | - | - | - |
Net Income to Common | -1.79 | -0.68 | -19.81 | -2.21 | -2.26 | -1.42 | -2.4 | -2.76 | -2.83 | -13.34 | -2.93 | -86.43 | -3.54 | 5.34 | -13.38 | -2.34 | -3.75 | -1.97 | -1.88 | -2.1 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 8 | 5 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 92 | 0 | 0 | 0 | 9 | 0 | 0 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 5 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 92 | 0 | 0 | 0 | 9 | 0 | 0 |
Shares Change (YoY) | 160.58% | 308.95% | 683.17% | 476.60% | 398.23% | 826.75% | 916.31% | 1536.54% | 2291.01% | -99.77% | 40.84% | -26.11% | -62.23% | 867.65% | - | - | - | - | - | - |
EPS (Basic) | -0.22 | -0.08 | -2.56 | -0.46 | -0.73 | -0.71 | -2.43 | -3.31 | -4.53 | -62.08 | -30.18 | -1694.12 | -135.88 | 0.06 | -193.74 | -33.82 | -54.29 | -0.21 | -27.23 | -30.34 |
EPS (Diluted) | -0.22 | -0.08 | -2.56 | -0.46 | -0.73 | -0.71 | -2.43 | -3.31 | -4.53 | -62.08 | -30.18 | -1694.12 | -135.88 | 0.06 | -193.74 | -33.82 | -54.29 | -0.21 | -27.23 | -30.34 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | -0.55 | -2.1 | -2.04 | -2.14 | -1.29 | -2.27 | -2.75 | -2.82 | -1.77 | -2.9 | -5.15 | -4.59 | -5.18 | -3.39 | -1.88 | -3.37 | -1.77 | -2.11 | -1.85 |
D&A For EBITDA | - | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -1.3 | -0.55 | -2.1 | -2.04 | -2.14 | -1.29 | -2.27 | -2.75 | -2.83 | -1.78 | -2.9 | -5.15 | -4.59 | -5.19 | -3.4 | -1.88 | -3.37 | -1.78 | -2.11 | -1.85 |